Skip to search formSkip to main contentSkip to account menu

neuroblastoma screening

Known as: Screening for Neuroblastoma, early detection of neuroblastoma, neuroblastoma early detection 
The use of any device, marker, or other means for the purpose of detecting the presence of neuroblastoma, usually before there are symptoms.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
PURPOSE To determine the usefulness of 6-month screening for neuroblastoma. PATIENTS AND METHODS The cumulative incidence rates… 
2001
2001
BACKGROUND Neuroblastoma has several characteristics that suggest that preclinical diagnosis might improve outcome. Therefore… 
1998
1998
Mass screening of infants for neuroblastoma began in Japan after studies suggested that survival rates could be improved by early… 
1998
1998
We read with great interest the article by Yamashita et al., who suggest a direct correlation between the plasma thrombospondin… 
1996
1996
Using data from the Japan Children's Cancer Registry, we estimated the age‐specific incidence rates of neuroblastoma. Before the… 
1991
1991
The justification for a neuroblastoma screening program has been discussed controversially. The analysis of 701 patients of the… 
Highly Cited
1990
Highly Cited
1990
A large neuroblastoma screening study was recently started in the province of Quebec, Canada. This project, a collaboration… 
1987
1987
We describe a simple and rapid method for measuring catecholamine metabolites in urine collected on filter paper. By this method… 
Highly Cited
1984
Highly Cited
1984
Since July 1973, the authors began developing a mass screening system using a VMA (vanilmandelic acid) spot test on 6‐to‐7 month…